
Incyte Corporation
INCYHealthcare|Biotechnology|US
$119.65
+1.64 (+1.39%)
DCF Value
$113.08
Tangible Book / Share
$26.60
Graham Number
$35.21
Cash / Share
$18.97
Ownership Breakdown
99.1%
Float
203.8M
Shares Outstanding
202.0M
Float Shares
Major Holders (11)
Combined: 87.4%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Felix J. Baker | HC, IN | 15.60% | 31,225,572 | May 11, 2026 | 13D/G |
| Julian C. Baker | HC, IN | 15.60% | 31,223,155 | May 11, 2026 | 13D/G |
| Baker Bros. Advisors (GP) LLC | HC, OO | 15.40% | 30,865,077 | May 11, 2026 | 13D/G |
| Baker Bros. Advisors LP | IA, PN | 15.40% | 30,865,077 | May 11, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 7.80% | 15,242,171 | Oct 17, 2025 | 13D/G |
| Vanguard Capital Management | Investment adviser | 6.32% | 12,591,630 | Apr 30, 2026 | 13D/G |
| Dodge & Cox | Investment adviser | 6.20% | 12,252,356 | May 14, 2026 | 13D/G |
| State Street Corporation | Holding company | 5.00% | 9,677,414 | Nov 10, 2025 | 13D/G |
| FBB Associates | PN, OO | 0.02% | 33,410 | May 11, 2026 | 13D/G |
| FBB3 LLC | Other | 0.02% | 31,140 | May 11, 2026 | 13D/G |
| FBB2, LLC | Other | 0.01% | 14,755 | May 11, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,371,104 acquired · 520,557 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Tray Thomas | Principal Accounting Officer | Nov 3, 2026 | SELL | 610 | $118.96 | $72.6K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Oct 15, 2026 | OPTION EX. | 925 | $64.25 | $59.4K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Oct 15, 2026 | OPTION EX. | 455 | $61.18 | $27.8K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Oct 15, 2026 | OPTION EX. | 423 | $61.76 | $26.1K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Oct 15, 2026 | OPTION EX. | 839 | $71.93 | $60.3K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Oct 15, 2026 | SELL | 2,642 | $112.71 | $297.8K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Oct 15, 2026 | OPTION EX. | 925 | $64.25 | $59.4K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Oct 15, 2026 | OPTION EX. | 839 | $71.93 | $60.3K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Oct 15, 2026 | OPTION EX. | 455 | $61.18 | $27.8K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Oct 15, 2026 | OPTION EX. | 423 | $61.76 | $26.1K | Form 4 |
| Heeson Lee | EVP, Head of Incyte Intl | Oct 1, 2026 | TAX W/H | 463 | $117.14 | $54.2K | Form 4 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | Sep 30, 2026 | AWARD | 322 | — | — | Form 4 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | Sep 30, 2026 | AWARD | 322 | — | — | Form 4 |
| Clancy Paul J | director | Sep 30, 2026 | AWARD | 203 | $121.35 | $24.6K | Form 4 |
| HARRIGAN EDMUND | director | Sep 30, 2026 | AWARD | 206 | $121.35 | $25.0K | Form 4 |
| Gardner David H | EVP, Chief Strategy Officer | Sep 22, 2026 | TAX W/H | 920 | $126.93 | $116.8K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Sep 15, 2026 | OPTION EX. | 9,233 | $71.93 | $664.1K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Sep 15, 2026 | OPTION EX. | 6,477 | $64.25 | $416.1K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Sep 15, 2026 | SELL | 9,233 | $120.50 | $1.1M | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Sep 15, 2026 | OPTION EX. | 4,551 | $61.18 | $278.4K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Sep 15, 2026 | OPTION EX. | 2,957 | $61.76 | $182.6K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Sep 15, 2026 | SELL | 13,985 | $120.49 | $1.7M | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Sep 15, 2026 | OPTION EX. | 6,477 | $64.25 | $416.1K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Sep 15, 2026 | OPTION EX. | 9,233 | $71.93 | $664.1K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Sep 15, 2026 | OPTION EX. | 4,551 | $61.18 | $278.4K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Sep 15, 2026 | OPTION EX. | 2,957 | $61.76 | $182.6K | Form 4 |
| Basi Ramitpal K | EVP, Human Resources | Aug 25, 2026 | TAX W/H | 504 | $129.72 | $65.4K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Aug 19, 2026 | SELL | 10,801 | $125.56 | $1.4M | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Aug 12, 2026 | SELL | 10,803 | $120.04 | $1.3M | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Aug 5, 2026 | SELL | 10,640 | $122.69 | $1.3M | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Aug 5, 2026 | OPTION EX. | 2,207 | $106.47 | $235.0K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Aug 5, 2026 | SELL | 2,207 | $123.99 | $273.6K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Aug 5, 2026 | OPTION EX. | 2,207 | $106.47 | $235.0K | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Jul 31, 2026 | SELL | 15,888 | $119.70 | $1.9M | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 326 | $105.43 | $34.4K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 85 | $106.47 | $9.0K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,293 | $90.56 | $207.7K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 1,642 | $85.01 | $139.6K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,623 | $83.58 | $219.2K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 3,023 | $83.20 | $251.5K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 1,643 | $80.50 | $132.3K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,864 | $77.67 | $222.4K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,623 | $74.78 | $196.1K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | SELL | 14,661 | $119.46 | $1.8M | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 9,459 | $72.27 | $683.6K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | SELL | 5,332 | $119.42 | $636.7K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | SELL | 2,187 | $119.47 | $261.3K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,072 | $71.93 | $149.0K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | SELL | 6,171 | $119.43 | $737.0K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 3,148 | $68.62 | $216.0K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,709 | $61.76 | $167.3K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | SELL | 4,695 | $119.39 | $560.5K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,284 | $64.25 | $146.7K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Aug 3, 2026 | OPTION EX. | 6,055 | $105.43 | $638.4K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | SELL | 2,864 | $119.40 | $342.0K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,918 | $61.18 | $178.5K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | SELL | 1,643 | $119.51 | $196.4K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | SELL | 1,642 | $119.38 | $196.0K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | SELL | 85 | $122.19 | $10.4K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | SELL | 326 | $121.69 | $39.7K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | SELL | 2,293 | $119.41 | $273.8K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Aug 3, 2026 | SELL | 6,055 | $120.43 | $729.2K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 326 | $105.43 | $34.4K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,284 | $64.25 | $146.7K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,072 | $71.93 | $149.0K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 85 | $106.47 | $9.0K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,918 | $61.18 | $178.5K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,709 | $61.76 | $167.3K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 3,023 | $83.20 | $251.5K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,864 | $77.67 | $222.4K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 1,642 | $85.01 | $139.6K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,293 | $90.56 | $207.7K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 3,148 | $68.62 | $216.0K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Aug 3, 2026 | OPTION EX. | 6,055 | $105.43 | $638.4K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 9,459 | $72.27 | $683.6K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,623 | $74.78 | $196.1K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 1,643 | $80.50 | $132.3K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 31, 2026 | OPTION EX. | 2,623 | $83.58 | $219.2K | Form 4 |
| Morrissey Michael James | EVP, Head of Tech. Operations | Jul 23, 2026 | AWARD | 8,999 | — | — | Form 4 |
| Morrissey Michael James | EVP, Head of Tech. Operations | Jul 23, 2026 | AWARD | 6,426 | $116.69 | $749.8K | Form 4 |
| Heeson Lee | EVP, Head of Incyte Intl | Jul 23, 2026 | AWARD | 15,423 | $116.69 | $1.8M | Form 4 |
| Heeson Lee | EVP, Head of Incyte Intl | Jul 23, 2026 | AWARD | 13,498 | — | — | Form 4 |
| Tray Thomas | Principal Accounting Officer | Jul 16, 2026 | AWARD | 2,834 | — | — | Form 4 |
| Tray Thomas | Principal Accounting Officer | Jul 16, 2026 | AWARD | 4,079 | $116.65 | $475.8K | Form 4 |
| Stein Steven H | CMO & Head of Late-Stage Dev. | Jul 16, 2026 | AWARD | 42,298 | $116.65 | $4.9M | Form 4 |
| Stein Steven H | CMO & Head of Late-Stage Dev. | Jul 16, 2026 | AWARD | 9,798 | — | — | Form 4 |
| Stein Steven H | CMO & Head of Late-Stage Dev. | Jul 16, 2026 | AWARD | 24,496 | — | — | Form 4 |
| Stein Steven H | CMO & Head of Late-Stage Dev. | Jul 16, 2026 | SELL | 1,877 | $114.73 | $215.3K | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 16, 2026 | AWARD | 5,916 | — | — | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 16, 2026 | AWARD | 25,538 | $116.65 | $3.0M | Form 4 |
| Mayes Patrick A | EVP & Chief Scientific Officer | Jul 16, 2026 | AWARD | 14,790 | — | — | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Jul 16, 2026 | AWARD | 13,403 | — | — | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Jul 16, 2026 | AWARD | 57,861 | $116.65 | $6.7M | Form 4 |
| CAGNONI PABLO J | President, Global Head of R&D | Jul 16, 2026 | AWARD | 33,508 | — | — | Form 4 |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | Jul 16, 2026 | AWARD | 7,857 | — | — | Form 4 |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | Jul 16, 2026 | SELL | 1,093 | $115.01 | $125.7K | Form 4 |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | Jul 16, 2026 | AWARD | 33,918 | $116.65 | $4.0M | Form 4 |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | Jul 16, 2026 | AWARD | 19,643 | — | — | Form 4 |
| Basi Ramitpal K | EVP, Human Resources | Jul 16, 2026 | AWARD | 21,548 | $116.65 | $2.5M | Form 4 |
| Basi Ramitpal K | EVP, Human Resources | Jul 16, 2026 | AWARD | 12,479 | — | — | Form 4 |
Congress & Senate Trades (18)
Ro KhannaHouse · CA17Sep 4, 2026
Robert P. BresnahanHouse · PA08May 15, 2025
Ro KhannaHouse · CA17Sep 9, 2024
Ro KhannaHouse · CA17Mar 25, 2024
Ro KhannaHouse · CA17Oct 10, 2023
Ro KhannaHouse · CA17Oct 2, 2023
Ro KhannaHouse · CA17Sep 6, 2023
Ro KhannaHouse · CA17Jun 29, 2023
Ro KhannaHouse · CA17Jun 26, 2023
Ro KhannaHouse · CA17May 19, 2023
Ro KhannaHouse · CA17Mar 14, 2023
Daniel GoldmanHouse · NY10Mar 6, 2023
Ro KhannaHouse · CA17Jan 9, 2023
Ro KhannaHouse · CA17Dec 6, 2022
Gilbert CisnerosHouse · CA31Dec 22, 2020
Gilbert CisnerosHouse · CA31Sep 16, 2020
Shelley Moore CapitoSenate · WVNov 12, 2018
Shelley Moore CapitoSenate · WVSep 8, 2017